Events

Kinase 2027: 12th SCI-RSC Symposium on Kinase Modulators

Event
12th RSC/SCI Symposium on Kinase Modulators

Dates
Monday 10 May – Tuesday 11 May, 2027

Place
AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK

Synopsis
With more than 100 clinically approved small molecules, the field of kinase modulation continues to attract significant investment from the drug discovery community and attention from academia. The 12th SCI-RSC symposium on kinase modulator design will encompass plenary lectures on emerging topics and case studies of ongoing programmes as well as successful past programmes. A range of topics including brain penetrant and inhaled kinase inhibitors, kinase chemical probes, allosteric modulators, targeted kinase protein degradation and kinase inhibition for non-oncology indications will be covered, along with views and perspectives on the future directions of kinase modulator research.

Who should attend
This event is aimed at all scientists interested in furthering their knowledge of kinases and drug design. It will also have wider appeal to members of the drug discovery community eager to understand how enzyme inhibitor programmes are approached and executed across the pharmaceutical industry.

This event will bring together industrial and academic experts representing many of the leading institutions in kinase drug discovery, to discuss a selection of new and emerging topics within the fields of kinase therapeutics for oncology and non-oncology, and foster discussions within the wider industry through networking events such as poster sessions and industrial exhibitions.

Registration is now open
Please click here for the main conference website.

Organising Committee
Al Dosseter, Medchemica
Ray Finlay, AstraZeneca
Nicole Hamblin, Rathlin Therapeutics
Suzanne O’Connor, University of Dundee
Asier Unciti-Broceta, University of Edinburgh

Secretariat Contact and Further Information
SCI Conference Team
+44 (0)20759815611
E-mail